Zobrazeno 1 - 10
of 42
pro vyhledávání: '"11"'
Autor:
Daniel Re, Carolin Bannwarth, Ferdinand Kuhn-Régnier, Heribert Bohlen, Michel Siedek, Thomas C. Koslowsky, Wilfried Voiss, Edmund Skibowski, Volker Diehl, Martin R. Weihrauch
Publikováno v:
Journal of Clinical Oncology. 20:4338-4343
PURPOSE: Micrometastatic disease in bone marrow is of prognostic significance in colorectal cancer patients. However, detection rates of standard immunocytology are relatively low. We used magnetic activated cell sorting (MACS), a highly sensitive me
Publikováno v:
Journal of Clinical Oncology. 17:3221-3225
PURPOSE: To describe the efficacy of oral etoposide against resistant stage 4 neuroblastoma. PATIENTS AND METHODS: Patients with refractory or recurrent stage 4 neuroblastoma were treated with etoposide 50 mg/m2 taken orally each day, in two or three
Publikováno v:
Journal of Clinical Oncology. 15:1730-1735
PURPOSE To evaluate the effect of two filgrastim dosages after autologous bone marrow transplantation (ABMT) in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). PATIENTS AND METHODS Eighty-six patients were enrolled onto a multi
Autor:
J Wolter, Korenblit Ad, Bruce C. McLeod, S G Taylor th, Carol M. Richman, Melody A. Cobleigh, Sharon Manson, Leonard A. Valentino, Richard G. Ghalie, Adler Ss
Publikováno v:
Journal of Clinical Oncology. 12:342-346
PURPOSE We investigated the role of high-dose chemotherapy and autologous bone marrow transplantation (ABMT) as the initial systemic treatment in patients with hormone-unresponsive metastatic breast cancer. We studied a regimen involving a split-cour
Autor:
Roy B. Jones, H N Claman, Scott I. Bearman, M. H. Purdy, Wilbur A. Franklin, Elizabeth J. Shpall, Tyler J. Curiel, Philip G. Archer, Salomon M. Stemmer, M. A. Bitter
Publikováno v:
Journal of Clinical Oncology. 12:28-36
PURPOSE To evaluate the capacity of enriched CD34-positive (CD34+) progenitor cells to reconstitute hematopoiesis in poor-prognosis breast cancer patients following administration of a high-dose alkylating agent chemotherapy regimen. PATIENTS AND MET
Autor:
Joachim Rom, Philipp Beckhove, Florian Schuetz, K. Ehlert, Andreas Schneeweiss, C. Sohn, Volker Schirrmacher
Publikováno v:
Journal of Clinical Oncology. 24:12502-12502
12502 Tumor-reactive CD4 and CD8 memory T cells (MTC) can be found in bone marrow (BM) of the majority of primary and metastatic breast cancer patients. In xenotransplant mouse models these cells, upon specific re-activation ex vivo, mediated efficie
Autor:
Ted Gooley, Emily Lansverk, Elihu H. Estey, Ajay K. Gopal, Mohamed L. Sorror, John M. Pagel, Min Fang, Brent L. Wood, Frederick R. Appelbaum, Jason W. Chien, Filippo Milano, Alexander I. Salter, Roland B. Walter
Publikováno v:
Journal of Clinical Oncology. 29:1190-1197
Purpose Allogeneic hematopoietic cell transplantation (HCT) benefits many patients with acute myeloid leukemia (AML) in first remission. Hitherto, little attention has been given to the prognostic impact of pretransplantation minimal residual disease
Autor:
Hannah R. Briemberg, Asher Chanan-Khan, Robert L. Schlossman, L. Thompson Heffner, Nikhil C. Munshi, David Avigan, Wanling Xie, Dixie Lee Esseltine, Deborah Doss, Hani Hassoun, Anthony A. Amato, David J. Kuter, Patrick Y. Wen, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Sagar Lonial, Santosh Kesari, Anne Louise Oaklander, Constantine S. Mitsiades
Publikováno v:
Journal of Clinical Oncology. 27:3518-3525
Purpose To assess efficacy and safety of single-agent bortezomib in previously untreated patients with multiple myeloma, investigate prevalence of baseline and treatment-emergent polyneuropathy, and identify molecular markers associated with response
Autor:
Rosales General, Jeri Kim, Shi Ming Tu, Christopher J. Logothetis, Funda Vakar-Lopez, Lance C. Pagliaro, Sue Hwa Lin, Sijin Wen, Frankin C. Wong, Donald A. Podoloff
Publikováno v:
Journal of Clinical Oncology. 23:7904-7910
Purpose Clinicians may have reservations about using strontium-89 for the treatment of bone metastases because of concerns that it may limit future use of chemotherapy. We assessed the rate of bone marrow failure in patients with prostate cancer who
Autor:
Sergio Cogliatti, Rolf A. Stahel, Michele Ghielmini, Hubert Schefer, Ursula Waltzer, Shu-Fang Hsu Schmitz, Nicolas Ketterer, Thomas Cerny, Mario Bargetzi, Francesco Bertoni, Martin F. Fey, Gabriella Pichert, Daniel Betticher
Publikováno v:
Journal of Clinical Oncology. 23:705-711
Purpose To evaluate the effect of single-agent rituximab given at the standard or a prolonged schedule in patients with newly diagnosed, or refractory or relapsed mantle cell lymphoma (MCL). Patients and Methods After induction treatment with the sta